Literature DB >> 20712750

Clinical course of children with a depressive spectrum disorder and transient manic symptoms.

Radha B Nadkarni1, Mary A Fristad.   

Abstract

OBJECTIVE: To assess rates of conversion to bipolar spectrum disorder (BPSD) and risk factors associated with conversion in children with depressive spectrum disorders (DSD) and transient manic symptoms (TMS) over 18 months. TMS are manic-like symptoms of insufficient duration or number to warrant a diagnosis of BPSD.
METHODS: Participants were 165 children (mean = 9.9 years, SD = 1.3) with mood disorders from the Multi-Family Psychoeducational Psychotherapy (MF-PEP) treatment study: 37 with DSD+TMS, 13 with DSD, and 115 with BPSD. All were assessed with standardized instruments on four occasions over 18 months, with half receiving MF-PEP after their baseline assessment and half receiving MF-PEP after a one-year wait-list condition.
RESULTS: At baseline, the Children's Global Assessment Scale scores did not differ significantly between the DSD+TMS, DSD, and BPSD groups. Conversion rates to BPSD were significantly higher for the DSD+TMS group (48.0%) compared to the DSD group (12.5%). Conversion was significantly more frequent for participants in the one-year wait-list control group (60%) compared to the immediate treatment group (16%). Clinical presentation, family environment, and family history did not differ significantly between the small subset of DSD+TMS participants who did convert to BPSD at follow-up and those who did not convert. Baseline functional impairment was greater for the converted group than the non-converted group.
CONCLUSIONS: Transient manic symptoms are a risk factor for eventual conversion to BPSD; psychoeducational psychotherapy may be protective. As this exploratory study had a small sample size and did not correct for multiple comparisons, additional studies with larger sample sizes are needed. (c) 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20712750      PMCID: PMC2924759          DOI: 10.1111/j.1399-5618.2010.00847.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  28 in total

1.  Phenomenology of children and adolescents with bipolar spectrum disorders.

Authors:  David Axelson; Boris Birmaher; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Jeffrey Bridge; Martin Keller
Journal:  Arch Gen Psychiatry       Date:  2006-10

2.  Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Authors:  Jon McClellan; Robert Kowatch; Robert L Findling
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-01       Impact factor: 8.829

3.  Relatives' awareness of their own expressed emotion as measured by a self-report adjective checklist.

Authors:  M S Friedmann; M J Goldstein
Journal:  Fam Process       Date:  1993-12

4.  Preliminary studies of the reliability and validity of the children's depression rating scale.

Authors:  E O Poznanski; J A Grossman; Y Buchsbaum; M Banegas; L Freeman; R Gibbons
Journal:  J Am Acad Child Psychiatry       Date:  1984-03

5.  Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions.

Authors:  Jules Angst; Robert Sellaro; Hans H Stassen; Alex Gamma
Journal:  J Affect Disord       Date:  2005-02       Impact factor: 4.839

6.  A 10-year prospective study of prodromal patterns for bipolar disorder among Amish youth.

Authors:  Jon A Shaw; Janice A Egeland; Jean Endicott; Cleona R Allen; Abram M Hostetter
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-11       Impact factor: 8.829

7.  The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum.

Authors:  Hagop S Akiskal; Franco Benazzi
Journal:  J Affect Disord       Date:  2006-02-20       Impact factor: 4.839

8.  Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder.

Authors:  B Geller; T B Cooper; D L Graham; H H Fetner; F A Marsteller; J M Wells
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-01       Impact factor: 8.829

9.  Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients.

Authors:  H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M Keller; M Warshaw; P Clayton; F Goodwin
Journal:  Arch Gen Psychiatry       Date:  1995-02

10.  Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children.

Authors:  B Geller; L W Fox; K A Clark
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-05       Impact factor: 8.829

View more
  32 in total

Review 1.  Functional impairment, stress, and psychosocial intervention in bipolar disorder.

Authors:  David J Miklowitz
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 2.  The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents.

Authors:  Marta Hauser; Christoph U Correll
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

Review 3.  Family-focused treatment for children and adolescents with bipolar disorder.

Authors:  David J Miklowitz
Journal:  Isr J Psychiatry Relat Sci       Date:  2012       Impact factor: 0.481

4.  Associations between sleep disturbance, cognitive functioning and work disability in Bipolar Disorder.

Authors:  Elaine M Boland; Jonathan P Stange; Ashleigh Molz Adams; Denise R LaBelle; Mian-Li Ong; Jessica L Hamilton; Samantha L Connolly; Chelsea L Black; Angelo B Cedeño; Lauren B Alloy
Journal:  Psychiatry Res       Date:  2015-10-09       Impact factor: 3.222

5.  Diagnostic profiles and clinical characteristics of youth referred to a pediatric mood disorders clinic.

Authors:  Marc J Weintraub; Eric A Youngstrom; Sarah E Marvin; Jennifer L Podell; Patricia D Walshaw; Eunice Y Kim; Robert L Suddath; Marcy J Forgey-Borlick; Brittany N Matkevich; David J Miklowitz
Journal:  J Psychiatr Pract       Date:  2014-03       Impact factor: 1.325

Review 6.  Early interventions for youths at high risk for bipolar disorder: a developmental approach.

Authors:  Xavier Benarous; Angèle Consoli; Vanessa Milhiet; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-09-22       Impact factor: 4.785

7.  The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.

Authors:  Christoph U Correll; Doreen M Olvet; Andrea M Auther; Marta Hauser; Taishiro Kishimoto; Ricardo E Carrión; Stephanie Snyder; Barbara A Cornblatt
Journal:  Bipolar Disord       Date:  2014-05-08       Impact factor: 6.744

8.  A Risk Calculator to Predict the Individual Risk of Conversion From Subthreshold Bipolar Symptoms to Bipolar Disorder I or II in Youth.

Authors:  Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-08-07       Impact factor: 8.829

9.  Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms.

Authors:  Danella Hafeman; David Axelson; Christine Demeter; Robert L Findling; Mary A Fristad; Robert A Kowatch; Eric A Youngstrom; Sarah McCue Horwitz; L Eugene Arnold; Thomas W Frazier; Neal Ryan; Mary Kay Gill; Jessica C Hauser-Harrington; Judith Depew; Brieana M Rowles; Boris Birmaher
Journal:  Bipolar Disord       Date:  2013-03-25       Impact factor: 6.744

Review 10.  Interventions for youth at high risk for bipolar disorder and schizophrenia.

Authors:  Robert K McNamara; Jeffrey R Strawn; Kiki D Chang; Melissa P DelBello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.